Convener’s Message

​

It is a distinct privilege to welcome you to the Advances in Proteomics Technology (APT) 2026 at IIT Bombay, a premier forum designed to bridge the gap between fundamental research and clinical implementation. As biomedical science moves toward a data-driven future, our mission is to provide a strategic ecosystem where academia, clinicians, and industry converge to translate high-dimensional omics discoveries into impactful healthcare solutions. By fostering a progressive vision of proteomics, we aim to lead the transition from reactive treatments toward a new era of predictive, preventive, and personalized medicine.

The central theme of APT 2026 emphasizes the critical integration of multi-omics technologies to decode the most direct functional readouts of biological systems. We are witnessing a profound paradigm shift where high-resolution mass spectrometry and advanced analytical workflows are no longer confined to discovery research but are actively informing clinical decision-making and biomarker development. This multidisciplinary synergy allows us to explore the clinical relevance of multi-omics for early diagnosis, patient stratification, and the advancement of targeted therapeutic strategies on a global scale.

To ensure a lasting impact on the next generation of researchers, we have created a comprehensive program featuring a five-day pre-conference internship, a two-day scientific exchange, and a dedicated hands-on workshop. This immersive experience is designed to provide in-depth training in the latest analytical platforms, equipping participants with the insights needed to redefine the future of translational research over the coming decade.

I warmly invite you to join us at IIT Bombay as we collectively harness the power of integrated omics to transform the landscape of modern healthcare.

Professor Sanjeeva Srivastava

Convenor, APT-2026

IIT Bombay